{"url_path":"/sec/cldww/8-k/2026-05-14/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 ** **Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-023094-index.html","accession_number":"0001493152-26-023094","cik":"0001855485","ticker":"CLDI","issuer_name":"Calidi Biotherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-023094-index.html","primary_entity_key":"0001855485","primary_entity_name":"Calidi Biotherapeutics, Inc."},"word_count":151,"has_tables":true,"body_markdown":"**Item 7.01** **Regulation FD Disclosure.**\n\n** **\n\nThe\ninformation under Item 2.02 above is incorporated herein by reference.\n\n \n\nBy\nfiling this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality\nof any information in this report that is required to be disclosed solely by reason of Regulation FD. The information in this Item 7.01\ndisclosure, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the\nSecurities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section.\nIn addition, the information in this Item 7.01 disclosure, including Exhibits 99.1, shall not be incorporated by reference into the filings\nof the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific\nreference in such filing."}